Latest filing published 09 Dec 2013 for Aevi Genomic Medicine, LLC, €9,510.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Clarence L. Dellio: trading record in brief
All filings by Clarence L. Dellio on record concern Aevi Genomic Medicine, LLC. We count 7 filings; the first trade dates from 11 September 2012 and the latest from 6 December 2013.
Market trades split into 2 purchases (€3,167) and 2 sales (€34k). Netting one side against the other leaves €31k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 2 option exercises. In 2013 alone, the filings show 2 purchases and 1 sale.
On 9 December 2013 came the latest disclosure, an open-market sale for €9,510 in Aevi Genomic Medicine, LLC. The last purchase on record was published on 5 June 2013, which is 4,905 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Clarence L. Dellio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$6.50Common StockSEC:0001144204-13-066378:0
- 288 shares@ US$4.14Common StockSEC:0001144204-13-033395:0Canonical exit: 1 Sept 2013 (T+90)
- 712 shares@ US$4.14Common StockSEC:0001144204-13-033395:1Canonical exit: 2 Sept 2013 (T+90)
- 3,500 shares@ US$3.64Common StockSEC:0001144204-13-016983:0
- 3,007 shares@ US$10.74Common StockSEC:0001144204-12-051883:0
- 4,300 shares@ US$3.64Common StockSEC:0001144204-12-051178:0
- 1,293 shares@ US$12.10Common StockSEC:0001144204-12-051178:1
7 of 7 declarations